Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUARTET: Apalutamide in mCSPC
NCT04601441Phase 4Unknown
- Sponsor
- Kindai University
- Start
- Nov 2020
- Primary completion
- Mar 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of apalutamide in prostate cancer (PCa), sponsored by Kindai University. Status: unknown.
02
Drugs
apalutamide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT04601441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04601441.